KRAS mutation predict response and outcome in advanced non-small cell lung carcinoma without driver alterations receiving PD-1 blockade immunotherapy combined with platinum-based chemotherapy: a retrospective cohort study from China
2022-01-01 Li, Q; Zhou, Q; Zhao, S; Wu, P; Shi, P; Zeng, J; Xiong, X; Chen, H; Kittaneh, M; Bravaccini, S; Zanoni, M; Zhou, C; Zhang, J
Long-term complete response in a patient with liver metastases from breast cancer treated with metronomic chemotherapy
2014-01-01 Cecconetto, L; Casadei Gardini, A; Tenti, E; Maltoni, R; Bravaccini, S; Oboldi, D; Zoli, W; Serra, P; Donati, C; Sarti, S; Amadori, D; Rocca, A.
Microbiota-Derived Metabolites in Tumor Progression and Metastasis
2020-01-01 Rossi, T; Vergara, D; Fanini, F; Maffia, M; Bravaccini, S; Pirini, F
Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissue
2013-01-01 Ulivi, P; Puccetti, M; Capelli, L; Chiadini, E; Bravaccini, S; Calistri, D; Zoli, W; Amadori, D; Candoli, P
New Biomarkers to Predict the Evolution of In Situ Breast Cancers
2014-01-01 Bravaccini, S; Tumedei, Mm; Scarpi, E; Zoli, W; Rengucci, C; Serra, L; Curcio, A; Buggi, F; Folli, S; Rocca, A; Maltoni, R; Puccetti, M; Amadori, D; Silvestrini, R
Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy
2016-01-01 Ulivi, P; Chiadini, E; Dazzi, C; Dubini, A; Costantini, M; Medri, L; Puccetti, M; Capelli, L; Calistri, D; Verlicchi, A; Gamboni, A; Papi, M; Mariotti, M; De Luigi, N; Scarpi, E; Bravaccini, S; Turolla, Gm; Amadori, D; Crino, L; Delmonte, A
Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer
2014-01-01 Rocca, A; Farolfi, A; Bravaccini, S; Schirone, A; Amadori, D
Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight
2022-01-01 Cortesi, M; Zanoni, M; Pirini, F; Tumedei, Mm; Ravaioli, S; Rapposelli, Ig; Frassineti, Gl; Bravaccini, S
Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report
2016-01-01 Gardini, Ac; Mariotti, M; Lucchesi, A; Pini, S; Valgiusti, M; Bravaccini, S; Del Monte, A; Burgio, Ma; Marisi, G; Amadori, D; Frassineti, Gl
Petals and Thorns in Programmed Death-Ligand 1 Testing: Is All Non-Small Cell Lung Cancer Diagnostic Material Suitable?
2018-01-01 Bravaccini, S; Bronte, G
Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy
2015-01-01 Rocca, A; Andreis, D; Fedeli, A; Maltoni, R; Sarti, S; Cecconetto, L; Pietri, E; Schirone, A; Bravaccini, S; Serra, P; Farolfi, A; Amadori, D
Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer
2019-01-01 Pietri, E; Massa, I; Bravaccini, S; Ravaioli, S; Tumedei, Mm; Petracci, E; Donati, C; Schirone, A; Piacentini, F; Gianni, L; Nicolini, M; Campadelli, E; Gennari, A; Saba, A; Campi, B; Valmorri, L; Andreis, D; Fabbri, F; Amadori, D; Rocca, A
Potential of telomerase expression and activity in cervical specimens as a diagnostic tool
2005-01-01 Bravaccini, S; Sanchini, Ma; Amadori, A; Medri, L; Saragoni, L; Calistri, D; Monti, F; Volpi, A; Amadori, D
Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study
2012-01-01 Ulivi, P; Capelli, L; Valgiusti, M; Zoli, W; Scarpi, E; Chiadini, E; Rosetti, P; Bravaccini, S; Calistri, D; Saragoni, L; Gardini, Ac; Ragazzini, A; Frassineti, Gl; Amadori, D; Passardi, A
Predictive role of telomerase activity in the clinical outcome of patients with benign lesions of the uterine cervix or CIN
2012-01-01 Bravaccini, S; Amadori, A; Scarpi, E; Tumedei, Mm; Zoli, W; Silvestrini, R
Primary epithelioid angiosarcoma of the thyroid: A case report
2021-01-01 Bravaccini, S; Caprara, L; Cortecchia, S; De Lillo, M; Lega, S; Poli, F; Tasca, I; Vacirca, A; Cimatti, Mc; Tumedei, Mm; Ravaioli, S; Puccetti, M
Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells
2005-01-01 Fabbri, F; Brigliadori, G; Ulivi, P; Tesei, A; Vannini, I; Rosetti, M; Bravaccini, S; Amadori, D; Bolla, M; Zoli, W
Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer
2019-01-01 D'Arcangelo, M; D'Incecco, A; Ligorio, C; Damiani, S; Puccetti, M; Bravaccini, S; Terracciano, L; Bennati, C; Minuti, G; Vecchiarelli, S; Landi, L; Milesi, M; Meroni, A; Ravaioli, S; Tumedei, Mm; Incarbone, M; Cappuzzo, F.
Progress with palbociclib in breast cancer: latest evidence and clinical considerations
2017-01-01 Rocca, A; Schirone, A; Maltoni, R; Bravaccini, S; Cecconetto, L; Farolfi, A; Bronte, G; Andreis, D
Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor-related pneumonitis
2022-01-01 Zhou, C; Yang, Y; Lin, X; Fang, N; Chen, L; Jiang, J; Deng, H; Deng, Y; Wan, M; Qiu, G; Sun, N; Wu, D; Long, X; Zhong, C; Xie, X; Xie, Z; Liu, M; Ouyang, M; Qin, Y; Petrella, F; Fiorelli, A; Bravaccini, S; Kataoka, Y; Watanabe, S; Goto, T; Solli, P; Igai, H; Saito, Y; Tsoukalas, N; Nakada, T; Li, S; Chen, R
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| KRAS mutation predict response and outcome in advanced non-small cell lung carcinoma without driver alterations receiving PD-1 blockade immunotherapy combined with platinum-based chemotherapy: a retrospective cohort study from China | 1-gen-2022 | Li, Q; Zhou, Q; Zhao, S; Wu, P; Shi, P; Zeng, J; Xiong, X; Chen, H; Kittaneh, M; Bravaccini, S; Zanoni, M; Zhou, C; Zhang, J | |
| Long-term complete response in a patient with liver metastases from breast cancer treated with metronomic chemotherapy | 1-gen-2014 | Cecconetto, L; Casadei Gardini, A; Tenti, E; Maltoni, R; Bravaccini, S; Oboldi, D; Zoli, W; Serra, P; Donati, C; Sarti, S; Amadori, D; Rocca, A. | |
| Microbiota-Derived Metabolites in Tumor Progression and Metastasis | 1-gen-2020 | Rossi, T; Vergara, D; Fanini, F; Maffia, M; Bravaccini, S; Pirini, F | |
| Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissue | 1-gen-2013 | Ulivi, P; Puccetti, M; Capelli, L; Chiadini, E; Bravaccini, S; Calistri, D; Zoli, W; Amadori, D; Candoli, P | |
| New Biomarkers to Predict the Evolution of In Situ Breast Cancers | 1-gen-2014 | Bravaccini, S; Tumedei, Mm; Scarpi, E; Zoli, W; Rengucci, C; Serra, L; Curcio, A; Buggi, F; Folli, S; Rocca, A; Maltoni, R; Puccetti, M; Amadori, D; Silvestrini, R | |
| Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy | 1-gen-2016 | Ulivi, P; Chiadini, E; Dazzi, C; Dubini, A; Costantini, M; Medri, L; Puccetti, M; Capelli, L; Calistri, D; Verlicchi, A; Gamboni, A; Papi, M; Mariotti, M; De Luigi, N; Scarpi, E; Bravaccini, S; Turolla, Gm; Amadori, D; Crino, L; Delmonte, A | |
| Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer | 1-gen-2014 | Rocca, A; Farolfi, A; Bravaccini, S; Schirone, A; Amadori, D | |
| Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight | 1-gen-2022 | Cortesi, M; Zanoni, M; Pirini, F; Tumedei, Mm; Ravaioli, S; Rapposelli, Ig; Frassineti, Gl; Bravaccini, S | |
| Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report | 1-gen-2016 | Gardini, Ac; Mariotti, M; Lucchesi, A; Pini, S; Valgiusti, M; Bravaccini, S; Del Monte, A; Burgio, Ma; Marisi, G; Amadori, D; Frassineti, Gl | |
| Petals and Thorns in Programmed Death-Ligand 1 Testing: Is All Non-Small Cell Lung Cancer Diagnostic Material Suitable? | 1-gen-2018 | Bravaccini, S; Bronte, G | |
| Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy | 1-gen-2015 | Rocca, A; Andreis, D; Fedeli, A; Maltoni, R; Sarti, S; Cecconetto, L; Pietri, E; Schirone, A; Bravaccini, S; Serra, P; Farolfi, A; Amadori, D | |
| Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer | 1-gen-2019 | Pietri, E; Massa, I; Bravaccini, S; Ravaioli, S; Tumedei, Mm; Petracci, E; Donati, C; Schirone, A; Piacentini, F; Gianni, L; Nicolini, M; Campadelli, E; Gennari, A; Saba, A; Campi, B; Valmorri, L; Andreis, D; Fabbri, F; Amadori, D; Rocca, A | |
| Potential of telomerase expression and activity in cervical specimens as a diagnostic tool | 1-gen-2005 | Bravaccini, S; Sanchini, Ma; Amadori, A; Medri, L; Saragoni, L; Calistri, D; Monti, F; Volpi, A; Amadori, D | |
| Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study | 1-gen-2012 | Ulivi, P; Capelli, L; Valgiusti, M; Zoli, W; Scarpi, E; Chiadini, E; Rosetti, P; Bravaccini, S; Calistri, D; Saragoni, L; Gardini, Ac; Ragazzini, A; Frassineti, Gl; Amadori, D; Passardi, A | |
| Predictive role of telomerase activity in the clinical outcome of patients with benign lesions of the uterine cervix or CIN | 1-gen-2012 | Bravaccini, S; Amadori, A; Scarpi, E; Tumedei, Mm; Zoli, W; Silvestrini, R | |
| Primary epithelioid angiosarcoma of the thyroid: A case report | 1-gen-2021 | Bravaccini, S; Caprara, L; Cortecchia, S; De Lillo, M; Lega, S; Poli, F; Tasca, I; Vacirca, A; Cimatti, Mc; Tumedei, Mm; Ravaioli, S; Puccetti, M | |
| Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells | 1-gen-2005 | Fabbri, F; Brigliadori, G; Ulivi, P; Tesei, A; Vannini, I; Rosetti, M; Bravaccini, S; Amadori, D; Bolla, M; Zoli, W | |
| Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer | 1-gen-2019 | D'Arcangelo, M; D'Incecco, A; Ligorio, C; Damiani, S; Puccetti, M; Bravaccini, S; Terracciano, L; Bennati, C; Minuti, G; Vecchiarelli, S; Landi, L; Milesi, M; Meroni, A; Ravaioli, S; Tumedei, Mm; Incarbone, M; Cappuzzo, F. | |
| Progress with palbociclib in breast cancer: latest evidence and clinical considerations | 1-gen-2017 | Rocca, A; Schirone, A; Maltoni, R; Bravaccini, S; Cecconetto, L; Farolfi, A; Bronte, G; Andreis, D | |
| Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor-related pneumonitis | 1-gen-2022 | Zhou, C; Yang, Y; Lin, X; Fang, N; Chen, L; Jiang, J; Deng, H; Deng, Y; Wan, M; Qiu, G; Sun, N; Wu, D; Long, X; Zhong, C; Xie, X; Xie, Z; Liu, M; Ouyang, M; Qin, Y; Petrella, F; Fiorelli, A; Bravaccini, S; Kataoka, Y; Watanabe, S; Goto, T; Solli, P; Igai, H; Saito, Y; Tsoukalas, N; Nakada, T; Li, S; Chen, R |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista16337
- 4 Contributo in Atti di Convegno ...2
- 2 Contributo in Volume1
Data di pubblicazione
- In corso di stampa18
- 2020 - 20277792
- 2010 - 20195948
- 2000 - 20091997
- 1990 - 1999523
- 1980 - 198961
- 1979 - 19791
Editore
- Trans Tech Publications1
Rivista
- INTERNATIONAL JOURNAL OF MOLECULA...240
- JOURNAL OF CLINICAL MEDICINE170
- CANCERS134
- INTERNATIONAL JOURNAL OF ENVIRONM...120
- DIAGNOSTICS88
- LNS. ACTIVITY REPORT85
- SCIENTIFIC REPORTS81
- PHD KORE REVIEW78
- RIVISTA DELLA COOPERAZIONE GIURID...76
- NUTRIENTS75
Serie
- ADVANCED MATERIALS RESEARCH1
- WORKING PAPERS RES1
Keyword
- COVID-19275
- Humans267
- Female142
- Male132
- SARS-CoV-2116
- inflammation110
- oxidative stress88
- Italy86
- Adult73
- Middle Aged72
Lingua
- eng11591
- ita2605
- fre66
- spa66
- ger12
- lat12
- por6
- ara3
- cat3
- enm3
Accesso al fulltext
- no fulltext16340